tirzepatide news update F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Lilly releases Zepbound® (tirzepatide) single-dose

Liver-Function & Detoxification Models Choline and Methionine help researchers explore fatty-liver dynamics and metabolic cleanup processes

The GLP-1 travel case guide recommends specific carrying solutions

Statements about panel composition describe common standards

In addition, liraglutide is a short-acting GLP-1 agonist, with subcutaneous dose of 1.25-1.9 mg per day, based on the pharmacokinetics results in rabbit, the inventors concluded that the drug concentration up to 50 mg/mL have to be used, with 2-4 doses per day, the frequent nasal dosing will potentially result in toxic effects, as well as poor patient compliance